A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors

Nature Communications

Volumn 1, Issue 7, 2010, Pages

  Mullasseril, Praseeda ^a   Hansen, Kasper B ^a   Vance, Katie M ^a   Ogden, Kevin K ^a   Yuan, Hongjie ^a   Kurtkaya, Natalie L ^a   Santangelo, Rose ^b   Orr, Anna G ^a   Le, Phuong ^a   Vellano, Kimberly M ^a   Liotta, Dennis C ^b   Traynelis, Stephen F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; TETRAHYDROISOQUINOLINE; TETRAHYDROISOQUINOLINE CIQ (3 CHLOROPHENYL)(6,7 DIMETHOXY 1 [(4 METHOXYPHENOXY)METHYL] 3,4 DIHYDROISOQUINOLIN 2(1H) YL)METHANONE); UNCLASSIFIED DRUG; NR2C NMDA RECEPTOR; NR2D NMDA RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN NERVE CELL; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SUBTHALAMIC NUCLEUS; ANIMAL; CELL STRAIN HEK293; METABOLISM; PATCH CLAMP; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; GLUTAMIC ACID; GLYCINE; HEK293 CELLS; HUMANS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84880252318     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1085     Document Type: Article

References (42)

1. Erreger, K., Chen, P. E., Wyllie, D. J.& Traynelis, S. F. Glutamate receptor gating. Crit. Rev. Neurobiol. 16, 187-224 (2004). (Pubitemid 40314700)
2. Coyle, J. T., Tsai, G.& Goff, D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann. NY Acad. Sci. 1003, 318-327 (2003). (Pubitemid 38083065)
3. Morris, B. J., Cochran, S. M.& Pratt, J. A. PCP: from pharmacology to modelling schizophrenia. Curr. Opin. Pharmacol. 5, 101-106 (2005). (Pubitemid 40124542)
4. Wang, C. X.& Shuaib, A. NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Curr. Drug. Targets CNS Neurol. Disord. 4, 143-151 (2005). (Pubitemid 40612988)
5. Preskorn, S. et al. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J. Clin. Psychopharmacol. 28, 631-637 (2008).
6. Kalia, L., Kalia, S.& Salter, M. NMDA receptors in clinical neurology: Excitatory times ahead. Lancet Neurol. 7, 742-755 (2008). (Pubitemid 351957932)
7. Hallett, P.& Standaert, D. G. Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol. Ther 102, 155-174 (2004). (Pubitemid 38681014)
8. Stip, E., Chouinard, S.& Boulay, L. On the trail of a cognitive enhancer for the treatment of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 219-232 (2005). (Pubitemid 40202907)
9. Tamminga, C. The neurobiology of cognition in schizophrenia. J. Clin. Psychiatry 67, e11 (2006).
10. Lisman, J. E. et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31, 234-242 (2008).
11. Williams, K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44, 851-859 (1993). (Pubitemid 23317299)
12. Fischer, G. et al. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. J. Pharmacol. Exp. Ther 283 (1997).
13. Avenet, P. et al. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Neurosci. Lett. 223, 133-136 (1997). (Pubitemid 27112794)
14. Akazawa, C., Shigemoto, R., Bessho, Y., Nakanishi, S.& Mizuno, N. Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J. Comp. Neurol. 347, 150-160 (1994). (Pubitemid 24262237)
15. Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B.& Seeburg, P. H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540 (1994). (Pubitemid 24100885)
16. Watanabe, M., Mishina, M.& Inoue, Y. Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem. J. Comp. Neurol. 343, 520-531 (1994). (Pubitemid 24138946)
17. Karadottir, R., Cavelier, P., Bergersen, L.& Attwell, D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438, 1162-1166 (2005). (Pubitemid 41831686)
18. Salter, M.& Fern, R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438, 1167-1171 (2005). (Pubitemid 41831687)
19. Karavanova, I., Vasudevan, K., Cheng, J.& Buonanno, A. Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-ß-galactosidase knock-in mice. Mol. Cell. Neurosci. 34, 468-480 (2007). (Pubitemid 46335882)
20. Standaert, D. G., Testa, C. M., Young, A.& Penney J. B., Jr. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J. Comp. Neurol. 343, 1-16 (1994). (Pubitemid 24129523)
21. Wenzel, A., Villa, M., Mohler, H.& Benke, D. Developmental and regional expression of NMDA receptor subtypes containing the NR2D subunit in rat brain. J. Neurochem. 66, 1240-1248 (1996). (Pubitemid 26065924)
22. Standaert, D. G., Landwehrmeyer, B. G., Kerner, J. A., Penney, J. B.& Young, A. B. Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Brain Res. Mol. Brain Res. 42, 89-102 (1996). (Pubitemid 26345410)
23. Counihan, T. et al. Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: Mesencephalic dopaminergic neurons. J. Comp. Neurol. 390, 91-101 (1998). (Pubitemid 28083648)
24. Jones, S.& Gibb, A. J. Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones. J. Physiol. 569, 209-221 (2005). (Pubitemid 41701386)
25. Brothwell, S. L. C. et al. NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones. J. Physiol. 586, 739-750 (2008). (Pubitemid 351194114)
26. Rudolf, G. D. et al. Expression of N-methyl-D-aspartate glutamate receptor subunits in the prefrontal cortex of the rat. Neuroscience 73, 417-427 (1996). (Pubitemid 26168801)
27. Cauli, B. et al. Classification of fusiform neocortical interneurons based on unsupervised clustering. Proc. Natl Acad. Sci. USA 97, 6144-6149 (2000). (Pubitemid 30367537)
28. Porter, J. et al. Properties of bipolar VIPergic interneurons and their excitation by pyramidal neurons in the rat neocortex. Eur. J. Neurosci. 10, 3617-3628 (1998). (Pubitemid 29073919)
29. Hatton, C. J.& Paoletti, P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46, 261-274 (2005). (Pubitemid 40545781)
30. Traynelis, S. F., Hartley, M.& Heinemann, S. F. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268, 873-876 (1995).
31. Wyllie, D. J. A., Behe, P.& Colquhoun, D. Single-channel activations and concentration jumps: Comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors. J. Physiol. 510, 1-18 (1998). (Pubitemid 28351920)
32. Stern, P., Behe, P., Schoepfer, R.& Colquhoun, D. Single-channel conductances of NMDA receptors expressed from cloned cDNAs: Comparison with native receptors. Proc. R. Soc. London B. Biol. Sci. 250, 271-277 (1992). (Pubitemid 23029876)
33. Yuan, H., Hansen, K. B., Vance, K. M., Ogden, K. K.& Traynelis, S. F. Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J. Neurosci. 29, 12045-12058 (2009).
34. Sobolevsky, A. I., Rosconi, M. P.& Gouaux, E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462, 745-756 (2009).
35. Traynelis, S. F., Burgess, M. F., Zheng, F., Lyuboslavsky, P.& Powers, J. L. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J. Neurosci. 18, 6163-6175 (1998). (Pubitemid 28373224)
36. Dravid, S. M., Prakash, A.& Traynelis, S. F. Activation of recombinant NR1/NR2C NMDA receptors. J. Physiol. 586, 4425-4439 (2008).
37. Erreger, K.& Traynelis, S. F. Allosteric interaction between zinc and glutamate binding domains on NR2A causes desensitization of NMDA receptors. J. Physiol. 569, 381-393 (2005). (Pubitemid 41830109)
38. Chen, P. E. et al. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J. Physiol. 586, 227-245 (2008).
39. Qin, F. Restoration of single-channel currents using the segmental k-means method based on hidden Markov modeling. Biophys. J. 86, 1488-1501 (2004). (Pubitemid 38295584)
40. Colquhoun, D.& Sigworth, F. J. in Single-Channel Recording (eds Sakmann, B.& Neher, E.) Ch 19, 483-587 (Plenum, 1995).
41. Gaddum, J. H. Lognormal distributions. Nature 156, 463-466 (1945).
42. Christopoulos, A. Assessing the distribution of parameters in models of ligand-receptor interaction: To log or not to log. Trends Pharmacol. Sci. 19, 351-357 (1998). (Pubitemid 29011723)